Metalloproteinase-9 in the ocular surface of patients with implanted Boston type 1 keratoprosthesis.

Andrea C ArteagaMargaret C WeissRaiza PerezMaría Soledad Cortina

Published in: Cornea open (2023)

The KPro device appears to increase MMP-9 levels in the ocular surface. High MMP-9 levels may be associated with higher risk of complications. MMP-9 testing can be useful to assess subclinical ocular surface inflammation with a potential role in the postoperative care of KPro patients.

Keyphrases

end stage renal disease
ejection fraction
healthcare
chronic kidney disease
newly diagnosed
oxidative stress
patients undergoing
palliative care
peritoneal dialysis
quality improvement
pain management